BCM
VTAE

Bridgeway Capital Management’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Bridgeway Capital Management’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-60,350
Closed -$1.26M – 1497
2016
Q3 		$1.26M Hold
60,350
– – 0.02% 706
2016
Q2 		$651K Buy
60,350
+50,250
+498% +$430K 0.01% 939
2016
Q1 		$67K Hold
10,100
– – ﹤0.01% 1390
2015
Q4 		$183K Hold
10,100
– – ﹤0.01% 1320
2015
Q3 		$111K Hold
10,100
– – ﹤0.01% 1385
2015
Q2 		$145K Buy
+10,100
New +$137K ﹤0.01% 1397

Bridgeway Capital Management's VTAE Position: Q4 2016 in Review

Bridgeway Capital Management sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 60,350 shares — an estimated $1.26M sold.

Bridgeway Capital Management first reported a position in VTAE in Q2 2015 and held it in 6 quarters. The position peaked at $1.26M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

  • Bridgeway Capital Management reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
  • Bridgeway Capital Management sold 60,350 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $1.26M.
  • Bridgeway Capital Management first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q2 2015 and held it in 6 quarters.
  • Bridgeway Capital Management's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $1.26M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Bridgeway Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.